From: Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children
Variable | Statistics | Children n = 843 | Adults n = 907 | p value | Total n = 1750 |
---|---|---|---|---|---|
Sex | N (missing data) | 836 (7) | 902 (5) | 1738 (12) | |
Male | N (%) | 479 (57.3) | 346 (38.4) | <0.001 (S)* | 825 (47.5) |
Age (years) | N | 843 | 907 | 1738 | |
Mean ± SD | 10.5 ± 3.5 | 33.2 ± 11.7 | 22.3 ± 14.3 | ||
Family history of allergy | N (%) | 656 (77.8) | 577 (63.6) | <0.001 (S)* | 1233 (70.5) |
Polysensitization | N (%) | 466 (55.3) | 565 (62.3) | 0.003 (S)* | 1031 (58.9) |
Contact with pets | N (missing data) | 805 (38) | 874 (33) | 1679 (71) | |
Regular contact | N (%) | 421 (52.3) | 420 (48.1) | 0.082 (NS)* | 841 (50.1) |
Weight | N (missing data) | 812 (31) | 900 (7) | 1712 (38) | |
Obesity | N (%) | 92 (11.3) | 79 (8.8) | 0.079 (NS)* | 171 (9.8) |
Moderate or high risk of sleep apnea syndrome | N (%) | – | 148 (16.3) | – | |
Smoking status | N (missing data) | 792 (51) | 901 (6) | 1693 (57) | |
Current smoker or currently exposed to passive smoking | N (%) | 88 (11.1) | 119 (13.2) | 0.189 (NS)* | 207 (12.2) |
Sports activity | N (missing data) | 834 (9) | 905 (2) | 1739 (11) | |
No regular sports activity | N (%) | 411 (49.3) | 642 (70.9) | <0.001 (S)* | 1053 (60.6) |
Rhinitis assessment | N (missing data) | 762 (81) | 814 (93) | 1576 (174) | |
Persistent rhinitis | N (%) | 655 (86.0) | 732 (89.9) | 0.015 (S)* | 1387 (88.0) |
RTSS | Mean ± SD | 9.0 ± 3.4 | 9.8 ± 3.6 | <0.001 (S)# | 9.5 ± 3.5 |
TNSS | Mean ± SD | 7.3 ± 2.4 | 7.7 ± 2.4 | <0.001 (S)# | 7.5 ± 2.4 |
Asthma assessment | N | 843 | 907 | 1750 | |
Associated asthma | N (%) | 407 (48.3) | 329 (36.3) | <0.001 (S)** | 736 (42.1) |
Persistent asthma | N (%) | 211 (25.0) | 158 (17.4) | <0.001 (S)* | 369 (21.1) |
Previous treatments within the year before SLIT initiation | N | 843 | 907 | 1750 | |
Oral antihistamines | N (%) | 713 (84.6) | 822 (90.6) | <0.001 (S)** | 1535 (87.7) |
Nasal corticoids | N (%) | 452 (53.6) | 529 (58.3) | 0.048 (S)** | 981 (56.1) |
Asthma medicationsa | N (%) | 319 (78.4) | 257 (78.1) | 0.931 (NS)* | 576 (78.3) |